Your browser doesn't support javascript.
loading
Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition.
Shen, Ying; Li, Jie; Nitta, Masayuki; Futalan, Diahnn; Steed, Tyler; Treiber, Jeffrey M; Taich, Zack; Stevens, Deanna; Wykosky, Jill; Chen, Hong-Zhuan; Carter, Bob S; Becher, Oren J; Kennedy, Richard; Esashi, Fumiko; Sarkaria, Jann N; Furnari, Frank B; Cavenee, Webster K; Desai, Arshad; Chen, Clark C.
Afiliação
  • Shen Y; Center for Theoretical and Applied Neuro-Oncology, Moores Cancer Center, Division of Neurosurgery, University of California San Diego, La Jolla, CA, USA.
  • Li J; Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Nitta M; Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Futalan D; Center for Theoretical and Applied Neuro-Oncology, Moores Cancer Center, Division of Neurosurgery, University of California San Diego, La Jolla, CA, USA.
  • Steed T; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Treiber JM; Center for Theoretical and Applied Neuro-Oncology, Moores Cancer Center, Division of Neurosurgery, University of California San Diego, La Jolla, CA, USA.
  • Taich Z; Center for Theoretical and Applied Neuro-Oncology, Moores Cancer Center, Division of Neurosurgery, University of California San Diego, La Jolla, CA, USA.
  • Stevens D; Center for Theoretical and Applied Neuro-Oncology, Moores Cancer Center, Division of Neurosurgery, University of California San Diego, La Jolla, CA, USA.
  • Wykosky J; Center for Theoretical and Applied Neuro-Oncology, Moores Cancer Center, Division of Neurosurgery, University of California San Diego, La Jolla, CA, USA.
  • Chen HZ; San Diego Branch, Ludwig Institute for Cancer Research, University of California San Diego, La Jolla, CA, USA.
  • Carter BS; San Diego Branch, Ludwig Institute for Cancer Research, University of California San Diego, La Jolla, CA, USA.
  • Becher OJ; Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Kennedy R; Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Esashi F; Center for Theoretical and Applied Neuro-Oncology, Moores Cancer Center, Division of Neurosurgery, University of California San Diego, La Jolla, CA, USA.
  • Sarkaria JN; Departments of Pediatrics and Pathology, Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
  • Furnari FB; Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK.
  • Cavenee WK; The Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
  • Desai A; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
  • Chen CC; San Diego Branch, Ludwig Institute for Cancer Research, University of California San Diego, La Jolla, CA, USA.
Oncotarget ; 6(14): 11751-67, 2015 May 20.
Article em En | MEDLINE | ID: mdl-26059434

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dano ao DNA / Neoplasias Encefálicas / Proteínas Proto-Oncogênicas / Proteínas Serina-Treonina Quinases / Glioblastoma / Proteínas de Ciclo Celular / Receptores ErbB Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dano ao DNA / Neoplasias Encefálicas / Proteínas Proto-Oncogênicas / Proteínas Serina-Treonina Quinases / Glioblastoma / Proteínas de Ciclo Celular / Receptores ErbB Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos
...